The life science and chemical instrumentation market size has grown strongly in recent years. It will grow from $61.82 billion in 2025 to $66.94 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to expansion of pharmaceutical research activities, increasing laboratory automation, rising demand for quality control testing, growth of biotechnology research programs, increasing academic research funding.
The life science and chemical instrumentation market size is expected to see strong growth in the next few years. It will grow to $90.58 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing adoption of advanced omics technologies, rising investments in personalized medicine research, expansion of digital laboratories, growing focus on regulatory compliance automation, increasing demand for real-time analytical insights. Major trends in the forecast period include increasing adoption of automated analytical instruments, rising demand for high-throughput testing systems, growing integration of laboratory information systems, expansion of precision measurement technologies, enhanced focus on data integrity and compliance.
Rising investments in research and development are anticipated to drive the growth of the life science and chemical instrumentation sector in the coming years. Research and development involve structured and innovative activities focused on expanding scientific knowledge and creating new or enhanced products, technologies, and processes. The increase in research and development activity is largely supported by higher government funding aimed at fostering technological advancement and sustaining economic competitiveness. As research and development activities continue to expand rapidly, the life science and chemical instrumentation industry is experiencing growing demand, as organizations increasingly rely on advanced analytical, detection, and measurement tools to enable accurate and high-precision scientific research. For example, in September 2025, data from Eurostat indicated that research and development expenditure in the European Union accounted for 2.26% of gross domestic product in 2023, rising from 2.22% in 2022. Consequently, expanding investments in research and development are fueling demand for life science and chemical instrumentation.
Technological advancements in analytical instruments are a significant trend gaining traction in the life science and chemical instrumentation market. Leading companies in this sector are concentrating on delivering innovative technologies to enhance their market position. For example, in October 2023, Shimadzu Corporation, a Japanese manufacturer of analytical instruments, introduced the Brevis GC-2050. This instrument is designed for scalability, enabling connections to auto-samplers, mass spectrometers, and various other accessories, all while maintaining a compact width of just 35 cm. Additionally, it features a 30% reduction in energy consumption compared to traditional models and minimizes helium usage, thereby promoting environmental sustainability. The Brevis GC-2050 represents a compact and sophisticated gas chromatography system equipped with intelligent automated functionalities.
In August 2024, Spectris, a UK-based instrumentation company, acquired Micromeritics for $600 million. This acquisition aims to establish a leading global presence in particle characterization by leveraging Micromeritics' expertise in analytical instrumentation, thereby enhancing Spectris' offerings in high-growth markets such as clean technology. Through this strategic move, Spectris intends to provide a comprehensive suite of solutions that encompasses the entire customer workflow, from research and development to quality control. Micromeritics, based in Georgia, is known for manufacturing instruments that measure surface area, porosity, density, and chemical activity.
Major companies operating in the life science and chemical instrumentation market are Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., Waters Corporation, F. Hoffmann-La Roche Ltd., Illumina Inc., Shimadzu Corporation, General Electric Healthcare LLC, Hitachi High-Technologies Corporation, JEOL Ltd., Oxford Instruments PLC, Rigaku Corporation, Sigma-Aldrich Corporation, SRI Instruments, Analytik Jena AG, Biochrom Ltd., BioTek Instruments Inc., Cole-Parmer Instrument Company LLC, Eppendorf AG, Harvard Bioscience Inc., HORIBA Ltd., Labconco Corporation, Mettler-Toledo International Inc., New England Biolabs Inc., QIAGEN N.V.
North America was the largest region in the life science and chemical instrumentation market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the life science and chemical instrumentation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the life science and chemical instrumentation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the life science and chemical instrumentation market by increasing costs of imported sensors, analytical modules, spectrometers, chromatography components, and precision electronics. Pharmaceutical and research laboratories in North America and Europe are most affected due to dependence on imported high-end instruments, while Asia-Pacific faces cost pressures on export manufacturing. These tariffs are increasing capital expenditure and delaying equipment upgrades. However, they are also encouraging domestic instrument manufacturing, regional supplier development, and modular system innovation.
The life science and chemical instrumentation market research report is one of a series of new reports that provides life science and chemical instrumentation market statistics, including life science and chemical instrumentation industry global market size, regional shares, competitors with a life science and chemical instrumentation market share, detailed life science and chemical instrumentation market segments, market trends and opportunities, and any further data you may need to thrive in the life science and chemical instrumentation industry. This life science and chemical instrumentation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Life science and chemical instrumentation represent critical medical devices employed for quality testing, process control, and monitoring in manufacturing plants, as well as for assessing food product quality and managing laboratory data. These instruments play pivotal roles in overseeing and regulating processes across industrial research and development labs, the pharmaceutical sector, biotechnology, and academic institutions.
Key technologies within life science and chemical instrumentation encompass polymerase chain reaction (PCR), DNA sequencers, amplifiers, flow cytometry, spectroscopy, electrophoresis, chromatography, centrifuges, and various other methods. For instance, PCR, facilitating the rapid amplification of DNA segments, finds broad applications in cell culture, cancer research, drug discovery, genomics, in vitro fertilization, bioprocessing, metabolomics, proteomics, and other fields. These instruments cater to diverse end-users, including hospitals, diagnostic centers, pharmaceutical and biotech firms, contract research organizations (CROs), academia, and research institutes.
The life science and chemical instrumentation market consists of sales of medical equipment such as liquid chromatography, molecular spectroscopy, electron microscopes, and cell analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The life science and chemical instrumentation market size is expected to see strong growth in the next few years. It will grow to $90.58 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing adoption of advanced omics technologies, rising investments in personalized medicine research, expansion of digital laboratories, growing focus on regulatory compliance automation, increasing demand for real-time analytical insights. Major trends in the forecast period include increasing adoption of automated analytical instruments, rising demand for high-throughput testing systems, growing integration of laboratory information systems, expansion of precision measurement technologies, enhanced focus on data integrity and compliance.
Rising investments in research and development are anticipated to drive the growth of the life science and chemical instrumentation sector in the coming years. Research and development involve structured and innovative activities focused on expanding scientific knowledge and creating new or enhanced products, technologies, and processes. The increase in research and development activity is largely supported by higher government funding aimed at fostering technological advancement and sustaining economic competitiveness. As research and development activities continue to expand rapidly, the life science and chemical instrumentation industry is experiencing growing demand, as organizations increasingly rely on advanced analytical, detection, and measurement tools to enable accurate and high-precision scientific research. For example, in September 2025, data from Eurostat indicated that research and development expenditure in the European Union accounted for 2.26% of gross domestic product in 2023, rising from 2.22% in 2022. Consequently, expanding investments in research and development are fueling demand for life science and chemical instrumentation.
Technological advancements in analytical instruments are a significant trend gaining traction in the life science and chemical instrumentation market. Leading companies in this sector are concentrating on delivering innovative technologies to enhance their market position. For example, in October 2023, Shimadzu Corporation, a Japanese manufacturer of analytical instruments, introduced the Brevis GC-2050. This instrument is designed for scalability, enabling connections to auto-samplers, mass spectrometers, and various other accessories, all while maintaining a compact width of just 35 cm. Additionally, it features a 30% reduction in energy consumption compared to traditional models and minimizes helium usage, thereby promoting environmental sustainability. The Brevis GC-2050 represents a compact and sophisticated gas chromatography system equipped with intelligent automated functionalities.
In August 2024, Spectris, a UK-based instrumentation company, acquired Micromeritics for $600 million. This acquisition aims to establish a leading global presence in particle characterization by leveraging Micromeritics' expertise in analytical instrumentation, thereby enhancing Spectris' offerings in high-growth markets such as clean technology. Through this strategic move, Spectris intends to provide a comprehensive suite of solutions that encompasses the entire customer workflow, from research and development to quality control. Micromeritics, based in Georgia, is known for manufacturing instruments that measure surface area, porosity, density, and chemical activity.
Major companies operating in the life science and chemical instrumentation market are Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., Waters Corporation, F. Hoffmann-La Roche Ltd., Illumina Inc., Shimadzu Corporation, General Electric Healthcare LLC, Hitachi High-Technologies Corporation, JEOL Ltd., Oxford Instruments PLC, Rigaku Corporation, Sigma-Aldrich Corporation, SRI Instruments, Analytik Jena AG, Biochrom Ltd., BioTek Instruments Inc., Cole-Parmer Instrument Company LLC, Eppendorf AG, Harvard Bioscience Inc., HORIBA Ltd., Labconco Corporation, Mettler-Toledo International Inc., New England Biolabs Inc., QIAGEN N.V.
North America was the largest region in the life science and chemical instrumentation market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the life science and chemical instrumentation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the life science and chemical instrumentation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the life science and chemical instrumentation market by increasing costs of imported sensors, analytical modules, spectrometers, chromatography components, and precision electronics. Pharmaceutical and research laboratories in North America and Europe are most affected due to dependence on imported high-end instruments, while Asia-Pacific faces cost pressures on export manufacturing. These tariffs are increasing capital expenditure and delaying equipment upgrades. However, they are also encouraging domestic instrument manufacturing, regional supplier development, and modular system innovation.
The life science and chemical instrumentation market research report is one of a series of new reports that provides life science and chemical instrumentation market statistics, including life science and chemical instrumentation industry global market size, regional shares, competitors with a life science and chemical instrumentation market share, detailed life science and chemical instrumentation market segments, market trends and opportunities, and any further data you may need to thrive in the life science and chemical instrumentation industry. This life science and chemical instrumentation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Life science and chemical instrumentation represent critical medical devices employed for quality testing, process control, and monitoring in manufacturing plants, as well as for assessing food product quality and managing laboratory data. These instruments play pivotal roles in overseeing and regulating processes across industrial research and development labs, the pharmaceutical sector, biotechnology, and academic institutions.
Key technologies within life science and chemical instrumentation encompass polymerase chain reaction (PCR), DNA sequencers, amplifiers, flow cytometry, spectroscopy, electrophoresis, chromatography, centrifuges, and various other methods. For instance, PCR, facilitating the rapid amplification of DNA segments, finds broad applications in cell culture, cancer research, drug discovery, genomics, in vitro fertilization, bioprocessing, metabolomics, proteomics, and other fields. These instruments cater to diverse end-users, including hospitals, diagnostic centers, pharmaceutical and biotech firms, contract research organizations (CROs), academia, and research institutes.
The life science and chemical instrumentation market consists of sales of medical equipment such as liquid chromatography, molecular spectroscopy, electron microscopes, and cell analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Life Science and Chemical Instrumentation Market Characteristics
3. Life Science and Chemical Instrumentation Market Supply Chain Analysis
4. Global Life Science and Chemical Instrumentation Market Trends and Strategies
5. Life Science and Chemical Instrumentation Market Analysis of End Use Industries
7. Global Life Science and Chemical Instrumentation Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Life Science and Chemical Instrumentation Total Addressable Market (TAM) Analysis for the Market
9. Life Science and Chemical Instrumentation Market Segmentation
10. Life Science and Chemical Instrumentation Market Regional and Country Analysis
11. Asia-Pacific Life Science and Chemical Instrumentation Market
12. China Life Science and Chemical Instrumentation Market
13. India Life Science and Chemical Instrumentation Market
14. Japan Life Science and Chemical Instrumentation Market
15. Australia Life Science and Chemical Instrumentation Market
16. Indonesia Life Science and Chemical Instrumentation Market
17. South Korea Life Science and Chemical Instrumentation Market
18. Taiwan Life Science and Chemical Instrumentation Market
19. South East Asia Life Science and Chemical Instrumentation Market
20. Western Europe Life Science and Chemical Instrumentation Market
21. UK Life Science and Chemical Instrumentation Market
22. Germany Life Science and Chemical Instrumentation Market
23. France Life Science and Chemical Instrumentation Market
24. Italy Life Science and Chemical Instrumentation Market
25. Spain Life Science and Chemical Instrumentation Market
26. Eastern Europe Life Science and Chemical Instrumentation Market
27. Russia Life Science and Chemical Instrumentation Market
28. North America Life Science and Chemical Instrumentation Market
29. USA Life Science and Chemical Instrumentation Market
30. Canada Life Science and Chemical Instrumentation Market
31. South America Life Science and Chemical Instrumentation Market
32. Brazil Life Science and Chemical Instrumentation Market
33. Middle East Life Science and Chemical Instrumentation Market
34. Africa Life Science and Chemical Instrumentation Market
36. Life Science and Chemical Instrumentation Market Competitive Landscape and Company Profiles
37. Life Science and Chemical Instrumentation Market Other Major and Innovative Companies
40. Life Science and Chemical Instrumentation Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Life Science And Chemical Instrumentation Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses life science and chemical instrumentation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for life science and chemical instrumentation? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The life science and chemical instrumentation market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Technology: Polymerase Chain Reaction (PCR); DNA Sequencers and Amplifiers; Flow Cytometry; Spectroscopy; Electrophoresis; Chromatography; Centrifuges; Other Technologies2) By Application: Cell Culture And Cell Therapy; Cancer Research; Drug Discovery; Genomics; In Vitro Fertilization; Bioprocess; Metabolomics; Proteomics; Other Applications
3) By End Users: Hospitals And Diagnostic Centers; Pharmaceutical And Biotechnology Companies; Contract Research Organization (CRO); Academia And Research Institutes
Subsegments:
1) By Polymerase Chain Reaction (PCR): Real-Time PCR; Digital PCR; Standard PCR2) By DNA Sequencers And Amplifiers: Next-Generation Sequencing (NGS); Sanger Sequencing
3) By Flow Cytometry: Cell Sorting; Multiparameter Analysis
4) By Spectroscopy: UV-Vis Spectroscopy; Mass Spectrometry; Infrared Spectroscopy
5) By Electrophoresis: Gel Electrophoresis; Capillary Electrophoresis
6) By Chromatography: Gas Chromatography (GC); High-Performance Liquid Chromatography (HPLC)
7) By Centrifuges: Benchtop Centrifuges; Ultracentrifuges
8) By Other Technologies: Microarray Technology; Immunoassay
Companies Mentioned: Agilent Technologies Inc.; Becton Dickinson and Company; Bio-Rad Laboratories Inc.; Bruker Corporation; Danaher Corporation; PerkinElmer Inc.; Thermo Fisher Scientific Inc.; Waters Corporation; F. Hoffmann-La Roche Ltd.; Illumina Inc.; Shimadzu Corporation; General Electric Healthcare LLC; Hitachi High-Technologies Corporation; JEOL Ltd.; Oxford Instruments PLC; Rigaku Corporation; Sigma-Aldrich Corporation; SRI Instruments; Analytik Jena AG; Biochrom Ltd.; BioTek Instruments Inc.; Cole-Parmer Instrument Company LLC; Eppendorf AG; Harvard Bioscience Inc.; HORIBA Ltd.; Labconco Corporation; Mettler-Toledo International Inc.; New England Biolabs Inc.; QIAGEN N.V.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Life Science and Chemical Instrumentation market report include:- Agilent Technologies Inc.
- Becton Dickinson and Company
- Bio-Rad Laboratories Inc.
- Bruker Corporation
- Danaher Corporation
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
- Waters Corporation
- F. Hoffmann-La Roche Ltd.
- Illumina Inc.
- Shimadzu Corporation
- General Electric Healthcare LLC
- Hitachi High-Technologies Corporation
- JEOL Ltd.
- Oxford Instruments PLC
- Rigaku Corporation
- Sigma-Aldrich Corporation
- SRI Instruments
- Analytik Jena AG
- Biochrom Ltd.
- BioTek Instruments Inc.
- Cole-Parmer Instrument Company LLC
- Eppendorf AG
- Harvard Bioscience Inc.
- HORIBA Ltd.
- Labconco Corporation
- Mettler-Toledo International Inc.
- New England Biolabs Inc.
- QIAGEN N.V.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 66.94 Billion |
| Forecasted Market Value ( USD | $ 90.58 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
